SCHEMBL2255160

SCHEMBL2255160

O=C(O)c1ccc(-c2ccc(F)cc2)cc1CCCCCc1ccc2cc(O)ccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.49
RARA P10276 1/20 0.49
RARG P13631 1/20 0.49
HCAR2 Q8TDS4 4/20 0.43
PPARA Q07869 2/20 0.41
DCLRE1B Q9H816 2/20 0.40
STING1 Q86WV6 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
AKR1B10 O60218 1/20 0.39
AKR1A1 P14550 1/20 0.39
AKR1B1 P15121 1/20 0.39
CBR1 P16152 1/20 0.39
AKR1C4 P17516 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
KAT8 Q9H7Z6 2/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255006 0.99 RARB (0.47) RARBRARARARGHCAR2PPARA
SCHEMBL2255122 0.97 RARB (0.44) RARBRARARARGHCAR2PPARA
SCHEMBL2254854 0.92 EGFR (0.47) RARBRARARARGHCAR2PPARA
SCHEMBL2252452 0.81 BCL2L1 (0.46) RARBRARARARGHCAR2PPARA
SCHEMBL2255248 0.81 SOX18 (0.50) RARBRARARARGHCAR2DCLRE1B
SCHEMBL2251170 0.81 DCLRE1B (0.44) RARBRARARARGDCLRE1BDCLRE1A
SCHEMBL2257220 0.81 MTNR1A (0.46) DCLRE1BDCLRE1A
SCHEMBL2255008 0.80 BCL2L1 (0.46) RARBRARARARGHCAR2PPARA
SCHEMBL2255014 0.80 BCL2L1 (0.46) RARBRARARARGHCAR2PPARA
SCHEMBL2254380 0.79 DCLRE1B (0.43) RARBRARARARGHCAR2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 US disclosed
EP-1904047-A2 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-04-02 EP disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 US disclosed
WO-2007008627-A2 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 RARB 1484/4885RARA 2438/4885RARG 1596/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 RARB 1484/4885RARA 2438/4885RARG 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.